Business
Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform
Companies deepen partnership to advance automated, integrated microbiology quality controlLEXINGTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced a new multi-system order from Samsung Biologics for its Growth Direct platform. This follow-on o
About this update from Samsung Biologics Co., Ltd.
[{"type":"image","alt":"Rapid Micro Biosystems, Inc.","displaySize":"","headline":null,"caption":"Rapid Micro Biosystems, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":155,"url":"https://media.zenfs.com/en/globenewswire.com/f730ec7c95983a2372a93ee6e7f390c0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/t0NXhkXriNft2AMfxGKlHw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f730ec7c95983a2372a93ee6e7f390c0","width":300,"height":155},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/t0NXhkXriNft2AMfxGKlHw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIxNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/f730ec7c95983a2372a93ee6e7f390c0","width":300,"height":155}},"lazy":false},{"type":"text","content":"Companies deepen partnership to advance automated, integrated microbiology quality control","length":90,"tagName":"p"},{"type":"text","content":"LEXINGTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced a new multi-system order from Samsung Biologics for its Growth Direct platform.","length":393,"tagName":"p"},{"type":"text","content":"This follow-on order builds on the companies’ existing partnership and supports Samsung’s continued expansion of the Growth Direct platform to automate microbial quality control across its manufacturing network.","length":211,"tagName":"p"},{"type":"text","content":"“Samsung Biologics is a leading global contract development and manufacturing organization (CDMO) and we’re pleased to strengthen our partnership with this new multi-system order,” said Robert Spignesi, President and CEO of Rapid Micro Biosystems. “Their integrated plant design embeds advanced automation and digitalization capabilities, including seamless connectivity across operations - to consistently deliver high productivity and quality. The Growth Direct platform enhances that foundation by delivering faster time to results, greater accuracy, and stronger data integrity. We look forward to supporting Samsung as it continues scaling its next-generation manufacturing operations.”","length":691,"tagName":"p"},{"type"...